JPWO2022093373A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022093373A5 JPWO2022093373A5 JP2023525002A JP2023525002A JPWO2022093373A5 JP WO2022093373 A5 JPWO2022093373 A5 JP WO2022093373A5 JP 2023525002 A JP2023525002 A JP 2023525002A JP 2023525002 A JP2023525002 A JP 2023525002A JP WO2022093373 A5 JPWO2022093373 A5 JP WO2022093373A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- pharma
- acceptable salt
- ceutically acceptable
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063105669P | 2020-10-26 | 2020-10-26 | |
| US63/105,669 | 2020-10-26 | ||
| US202163193748P | 2021-05-27 | 2021-05-27 | |
| US63/193,748 | 2021-05-27 | ||
| PCT/US2021/047824 WO2022093373A1 (en) | 2020-10-26 | 2021-08-26 | Compounds,compositions and methods of use to treat bone fractures |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024506435A JP2024506435A (ja) | 2024-02-14 |
| JP2024506435A5 JP2024506435A5 (https=) | 2024-09-03 |
| JPWO2022093373A5 true JPWO2022093373A5 (https=) | 2024-09-03 |
Family
ID=81383093
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023525002A Pending JP2024506435A (ja) | 2020-10-26 | 2021-08-26 | 化合物、組成物、および骨折を処置するための使用方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20230399374A1 (https=) |
| EP (1) | EP4232074A4 (https=) |
| JP (1) | JP2024506435A (https=) |
| AU (1) | AU2021370296A1 (https=) |
| CA (1) | CA3194776A1 (https=) |
| MX (1) | MX2023004796A (https=) |
| WO (1) | WO2022093373A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018102616A1 (en) * | 2016-11-30 | 2018-06-07 | Purdue Research Foundation | Fracture targeted bone regeneration through parathyroid hormone receptor stimulation |
| WO2019232285A1 (en) | 2018-05-30 | 2019-12-05 | Purdue Research Foundation | Targeting anabolic drugs for accelerated fracture repair |
| WO2022093374A1 (en) * | 2020-10-26 | 2022-05-05 | Purdue Research Foundation | Compounds,compositions and methods of use to treat spinal fusions |
| AU2022205801A1 (en) * | 2021-01-05 | 2023-07-13 | Radius Health, Inc. | Treatment of long bone fractures with abaloparatide |
| CN117373681B (zh) * | 2023-10-30 | 2024-04-26 | 中国航天科工集团七三一医院 | 一种基于血糖调节系统作用的骨折愈合仿真方法及系统 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2883707A1 (en) * | 2012-08-28 | 2014-03-06 | The Governors Of The University Of Alberta | Parathyroid hormone, insulin, and related peptides conjugated to bone targeting moieties and methods of making and using thereof |
| WO2018102616A1 (en) * | 2016-11-30 | 2018-06-07 | Purdue Research Foundation | Fracture targeted bone regeneration through parathyroid hormone receptor stimulation |
| WO2019232285A1 (en) * | 2018-05-30 | 2019-12-05 | Purdue Research Foundation | Targeting anabolic drugs for accelerated fracture repair |
| WO2022093374A1 (en) * | 2020-10-26 | 2022-05-05 | Purdue Research Foundation | Compounds,compositions and methods of use to treat spinal fusions |
-
2021
- 2021-08-26 WO PCT/US2021/047824 patent/WO2022093373A1/en not_active Ceased
- 2021-08-26 MX MX2023004796A patent/MX2023004796A/es unknown
- 2021-08-26 JP JP2023525002A patent/JP2024506435A/ja active Pending
- 2021-08-26 AU AU2021370296A patent/AU2021370296A1/en active Pending
- 2021-08-26 EP EP21887113.5A patent/EP4232074A4/en active Pending
- 2021-08-26 CA CA3194776A patent/CA3194776A1/en active Pending
- 2021-08-26 US US18/033,665 patent/US20230399374A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102718858B (zh) | 胰高血糖素样肽-1类似物单体、二聚体及其制备方法与应用 | |
| US10960054B2 (en) | Fracture targeted bone regeneration through parathyroid hormone receptor stimulation | |
| TW202323296A (zh) | 組合療法 | |
| KR20170078668A (ko) | 이중 glp-1r 및 glp-2r 작용제 활성을 갖는 조성물 및 펩티드 | |
| WO2007081975A2 (en) | Method of treating multiple sclerosis | |
| RU2019112897A (ru) | Комбинаторная терапия с агонистами cnp контролируемого высвобождения | |
| JP2009544585A5 (https=) | ||
| JP2024506435A (ja) | 化合物、組成物、および骨折を処置するための使用方法 | |
| TW202304424A (zh) | 包含依維莫司和安森司群的組合 | |
| US20230390363A1 (en) | Compounds, Compositions and Methods of Use to Treat Spinal Fusions | |
| JPWO2022093373A5 (https=) | ||
| JP2004026678A (ja) | ２型糖尿病治療剤 | |
| WO1999059543A1 (en) | A pharmaceutical formulation for nasal administration | |
| JP4931306B2 (ja) | 骨形成を安全に促進させる医薬複合剤 | |
| JPWO2022093374A5 (https=) | ||
| RU2155588C2 (ru) | Способ увеличения массы костной ткани при переломах | |
| JP5300943B2 (ja) | 骨形成を安全に促進させる医薬複合剤 | |
| WO2002100811A1 (en) | S-methylcysteine s-ethylcysteine and related s-alkylthiols as antagonists to the effects of s-nitrosothiols and nitric oxide | |
| AU2006311227B2 (en) | Use of clodronic acid for the treatment of navicular syndrome | |
| JP5454805B2 (ja) | 骨形成を安全に促進させる医薬複合剤 | |
| CN116710068A (zh) | 用于治疗脊柱融合的化合物、组合物和方法 | |
| RU2023110696A (ru) | СПОСОБ ЛЕЧЕНИЯ IgA-НЕФРОПАТИИ С ИСПОЛЬЗОВАНИЕМ СЛИТОГО БЕЛКА TACI-FC | |
| TH1901005605A (th) | องค์ประกอบสำหรับการทรีทโรคข้อและชุดคิทที่มีสิ่งเดียวกัน | |
| EA200601581A1 (ru) | Пептид, стимулирующий регенерацию ткани печени, фармацевтическая композиция на его основе и способ ее применения | |
| RU2001131112A (ru) | Препаративная форма для введения в подвздошную кишку, включающая соединение, ингибирующее транспорт подвздошнокишечной желчной кислоты |